Switching from Labetalol to Lisinopril for Hypertension Management
Rationale and Recommendations
- The American College of Cardiology recommends ACE inhibitors like lisinopril as preferred agents for many patients with hypertension, especially those with heart failure, as they have been proven to reduce morbidity and mortality 2, 3
- Beta-blockers like labetalol are not recommended as first-line agents for hypertension unless the patient has specific indications such as ischemic heart disease or heart failure 1
Patient Assessment and Monitoring
- Measure baseline blood pressure and heart rate before starting the transition, and check blood pressure at least twice daily during the transition period 4
- Check baseline renal function (creatinine, eGFR) and serum potassium before starting lisinopril, and monitor for any signs of worsening renal function during the transition 5
Dose Adjustment and Titration
- The American College of Cardiology recommends titrating lisinopril as needed to reach target blood pressure after labetalol is discontinued, with a target dose of 20-40 mg once daily 2
- For patients with heart failure, the initial dose of lisinopril should be 5 mg once daily, with careful titration up to a target of 20-40 mg daily 3
Special Considerations and Potential Complications
- For patients with renal impairment, a small increase (up to 30%) in creatinine is often expected and acceptable when starting ACE inhibitors 6, 7, 8
- Monitor potassium levels, especially if the patient is on potassium-sparing diuretics or has renal impairment, to prevent hyperkalemia 5
- Abrupt discontinuation of beta-blockers like labetalol can lead to rebound hypertension, which is why a gradual taper is essential 1